FSNUY Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA (FSNUY) is expected to report earnings on November 4, 2026, before the market open. The stock has had a Post-Earnings Announcement Drift (PEAD) of +0.7% since its last earnings release on August 5, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Fresenius SE & Co. KGaA
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Sector
Healthcare
Industry
Home Health Care